J
James D. Faix
Researcher at Stanford University
Publications - 46
Citations - 4813
James D. Faix is an academic researcher from Stanford University. The author has contributed to research in topics: Maternal hypothyroidism & Thyroid function. The author has an hindex of 20, co-authored 46 publications receiving 4462 citations. Previous affiliations of James D. Faix include Beth Israel Deaconess Medical Center & Montefiore Medical Center.
Papers
More filters
Journal ArticleDOI
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child.
James E. Haddow,Glenn E. Palomaki,Walter C. Allan,Josephine Williams,George J. Knight,June Gagnon,Cheryl E. O’heir,Marvin L. Mitchell,Rosalie J. Hermos,Susan E. Waisbren,James D. Faix,Robert Z. Klein +11 more
TL;DR: Undiagnosed hypothyroidism in pregnant women may adversely affect their fetuses; therefore, screening for thyroid deficiency during pregnancy may be warranted.
Journal ArticleDOI
Maternal thyroid deficiency and pregnancy complications: implications for population screening.
Walter C. Allan,James E. Haddow,Glenn E. Palomaki,Josephine Williams,Marvin L. Mitchell,R J Hermos,James D. Faix,R. Z. Klein +7 more
TL;DR: From the second trimester onward, the major adverse obstetrical outcome associated with raised TSH in the general population is an increased rate of fetal death, which would be another reason to consider population screening.
Journal ArticleDOI
Biomarkers of sepsis
TL;DR: Combinations of pro- and anti-inflammatory biomarkers in a multi-marker panel may help identify patients who are developing severe sepsis before organ dysfunction has advanced too far, and these biomarkers may help to reduce the mortality rate associated with severe Sepsis which, despite advances in supportive measures, remains high.
Journal ArticleDOI
Prevalence of thyroid deficiency in pregnant women.
TL;DR: The present study was designed to determine the current prevalence of gestational hypothyroidism, since maternal thyroxine deficiency is associated with poor obstetric outcomes and mental retardation in the surviving offspring.
Journal Article
Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Graziella Abu-Jawdeh,James D. Faix,Niloff J,Kathi Tognazzi,Eleanor J. Manseau,Harold F. Dvorak,Lawrence F. Brown +6 more
TL;DR: The expression of VPF/VEGF and its receptors flt-1 and KDR in ovarian tumors is defined to suggest that VPF plays an important role in the angiogenesis associated with ovarian neoplasms.